Evidence map›Paper›PMID 28103298›Full record

ArticlePloS one2017

Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice.

Tiffany J Mellott, Olivia M Huleatt, Bethany N Shade, Sarah M Pender, Yi B Liu, Barbara E Slack, Jan K Blusztajn

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Prenatal choline supplementation improves child sustained attention: A 7-year follow-up of a randomized controlled feeding trial.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Tiffany J MellottDepartment of Pathology & Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Olivia M HuleattDepartment of Pathology & Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Bethany N ShadeDepartment of Pathology & Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Sarah M PenderDepartment of Pathology & Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Yi B LiuDepartment of Pathology & Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Barbara E SlackDepartment of Pathology & Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Jan K BlusztajnDepartment of Pathology & Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Boston University · US

Funding

TIME FRAMES OF CHOLINE ENHANCEMENT OF MEMORYP01AG009525 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BLUSZTAJN, JAN KRZYSZTOF · 1991 to 2010
$11.8M
BMP9 as a juvenile protective factor in cognitive agingR01AG045031 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BLUSZTAJN, JAN KRZYSZTOF · 2014 to 2018
$1.8M
NIA NIH HHS P01 AG009525NIA NIH HHS R01 AG045031
6 · The paper itself

Abstract

Prevention of Alzheimer's disease (AD) is a major goal of biomedical sciences. In previous studies we showed that high intake of the essential nutrient, choline, during gestation prevented age-related memory decline in a rat model. In this study we investigated the effects of a similar treatment on AD-related phenotypes in a mouse model of AD. We crossed wild type (WT) female mice with hemizygous APPswe/PS1dE9 (APP.PS1) AD model male mice and maintained the pregnant and lactating dams on a control AIN76A diet containing 1.1 g/kg of choline or a choline-supplemented (5 g/kg) diet. After weaning all offspring consumed the control diet. As compared to APP.PS1 mice reared on the control diet, the hippocampus of the perinatally choline-supplemented APP.PS1 mice exhibited: 1) altered levels of amyloid precursor protein (APP) metabolites-specifically elevated amounts of β-C-terminal fragment (β-CTF) and reduced levels of solubilized amyloid Aβ40 and Aβ42 peptides; 2) reduced number and total area of amyloid plaques; 3) preserved levels of choline acetyltransferase protein (CHAT) and insulin-like growth factor II (IGF2) and 4) absence of astrogliosis. The data suggest that dietary supplementation of choline during fetal development and early postnatal life may constitute a preventive strategy for AD.

Indexed as

Dietary SupplementsAlzheimer DiseaseAmyloid beta-Protein PrecursorAmyloidosisAnimalsAnimals, NewbornCholineCholine O-AcetyltransferaseDisease Models, AnimalFemaleHippocampusMaleMiceMice, Mutant StrainsMutant ProteinsNeurogenesisAmyloid beta-Protein PrecursorCholineCholine O-AcetyltransferaseMutant ProteinsPresenilin-1presenilin 1, mouse

Identifiers

PMID28103298
PMCPMC5245895
OpenAlexW2573457953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.